Withdrawn NCT05119894
This study was withdrawn. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 64 Years
Countries
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Completed NCT05402111
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT05463770
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT05542264
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT05628103
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Anaheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Terminated NCT04109950
This study was terminated in the United States, in Bulgaria, in Colombia, .... It is testing investigational Drug for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 65 Years
Countries United States, Bulgaria, Colombia, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04038957
This study is completed in the United Kingdom. It focuses on schizophrenia.
In London Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 45 Years
Countries United Kingdom
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04369391
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT05848700
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04865835
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Oakland Park Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04092686
This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing investigational Drug for schizophrenia.
Multiple locations, including Rogers Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Bulgaria, Croatia, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT06356389
This summary needs review. Please check the official study record and contact the research team for details.
In Shanghai Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries China
Sponsor Zhejiang Jingxin Pharmaceutical Co., Ltd.
Condition Schizophrenia